Idera Pharmaceuticals (IDRA) Announces Issuance of Patents Claiming Novel Toll-like Receptor-Targeted Immune Modulatory Oligonucleotides
Tweet Send to a Friend
Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) earlier announced the issuance ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
